Another COVID-19 variant is on the rise this fall, hot on the heels of a massive summer surge of the virus. The variant, ...
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...
The vaccines can reduce the risk of long COVID, which involves symptoms such as brain fog and fatigue that persist for months ...
PFE's non-COVID drugs and potential contribution from new and newly acquired products have started to drive growth.
In Depth
Mayo Clinic on MSN3dIn Depth
COVID-19 vaccines for kids: What you need to know
Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.
Targeting the KP.2 strain is expected to provide better protection against COVID-19 based on current data. The 2024-2025 mRNA COVID-19 vaccines will include a monovalent component that corresponds to ...
Today, Benzinga 's options scanner spotted 26 uncommon options trades for BioNTech. This isn't normal. The overall sentiment ...
Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the ...
COVID-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already ...